GALERA THERAPEUTICS INC
COM · CUSIP 36338D108
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($4.6m this quarter). Holder counts are more reliable. Implied quarter-end price ≈ $9.83.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 33 |
| Q1 2020 | 35 |
| Q2 2020 | 42 |
| Q3 2020 | 45 |
| Q4 2020 | 52 |
| Q1 2021 | 55 |
| Q2 2021 | 48 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 17 | 12 |
| Q2 2020 | 29 | 5 |
| Q3 2020 | 12 | 16 |
| Q4 2020 | 28 | 9 |
| Q1 2021 | 25 | 20 |
| Q2 2021 | 22 | 31 |
Biggest buyers
| AIGH Capital Management LLC | Added | +1.1m |
| DEUTSCHE BANK AG\ | Added | +269.8k |
| Worth Venture Partners, LLC | Added | +254.9k |
| PERCEPTIVE ADVISORS LLC | Added | +254.7k |
| Altium Capital Management LLC | New | +219.9k |
| MILLENNIUM MANAGEMENT LLC | New | +118.5k |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Added | +113.9k |
| MARSHALL WACE, LLP | Added | +62.4k |
| Ergoteles LLC | New | +40.0k |
| Tibra Equities Europe Ltd | New | +36.9k |
Biggest sellers
| BlackRock Inc. | Reduced | -406.6k |
| SPHERA FUNDS MANAGEMENT LTD. | Sold out | -323.3k |
| CAAS CAPITAL MANAGEMENT LP | Sold out | -273.2k |
| STATE STREET CORP | Reduced | -112.0k |
| NORTHERN TRUST CORP | Reduced | -80.2k |
| Schonfeld Strategic Advisors LLC | Sold out | -54.5k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -45.0k |
| PANAGORA ASSET MANAGEMENT INC | Reduced | -35.6k |
| Bank of New York Mellon Corp | Sold out | -32.3k |
| Weiss Multi-Strategy Advisers LLC | Sold out | -26.6k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Emerald Bioventures, LLC
13D · may seek influence
+3.7 pts · filed 2026-05-29
Stated purposeItem 4 of the Original 13D is supplemented and amended, as the case may be, as follows: On May 14, 2026, the Issuer provided Emerald with a Notice of Mandatory Conversion of Series B Non-Voting Convertible Preferred Stock (the "Mandatory Conversion Notice") effective May 15, 2026 (the "Mandatory Conversion"). In connection with the Mandatory Conversion, 20,813.8186192892 shares of Series B Preferred Stock held by Emerald were converted into 20,813,818 shares of Common Stock. In lieu of fractional shares to which Emerald was entitled, the Company is required to pay Emerald an amount of cash equal to such fraction multiplied by the closing price of a share of Common Stock on the applicable Trading Market (as defined in the Certificate of Designation) on the date of the Mandatory Conversio… Full filing |
30.2% |
Hyare Parvinder Singh
13D · may seek influence
new · filed 2026-06-11
Stated purposeThe response to Item 6 of this Schedule 13D is incorporated herein by reference. Nova MergerOn December 30, 2024, the Issuer entered into an Agreement and Plan of Merger (the "Nova Merger Agreement"), by and among the Issuer, Grape Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Grape Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Second Merger Sub") and Nova Pharmaceuticals, Inc., a Delaware corporation ("Nova"), on December 30, 2024 (the "Closing"), the Issuer acquired Nova. In accordance with the Nova Merger Agreement, First Merger Sub merged with and into Nova (the "First Merger"), with Nova surviving as a wholly owned subsidiary of the Issuer. Following the First Merger … Full filing |
6.7% |
CHANG NANCY T
13D · may seek influence
new · filed 2026-04-10
Stated purposeThe responses to Items 3 and 6 of this Schedule 13D are incorporated herein by reference. Pursuant to the Agreement and Plan of Merger, dated December 30, 2024 (the "Merger Agreement"), by and among the Issuer, Grape Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Issuer ("First Merger Sub"), Grape Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Issuer ("Second Merger Sub"), and Nova Pharmaceuticals, Inc., a Delaware corporation ("Nova"), on December 30, 2024 (the "Closing"), the Issuer acquired Nova. In accordance with the Merger Agreement, First Merger Sub merged with and into Nova (the "First Merger"), with Nova surviving as a wholly owned subsidiary of the Issuer. Following the First Merger and as part of … Full filing |
5.9% |
Fell to 5% or below in the last year: Ikarian Capital, LLC (0.0%, 2026-08-14)
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| NEA Management Company, LLC 0.56% of their portfolio | 4.4m $42.9m | Unchanged |
| Sofinnova Investments, Inc. 1.84% of their portfolio | 3.1m $30.3m | Unchanged |
| NOVO HOLDINGS A/S 1.07% of their portfolio | 2.5m $24.2m | Unchanged |
| AIGH Capital Management LLC 5.39% of their portfolio | 2.0m $19.9m | Added +1.1m |
| Blackstone Inc. 0.04% of their portfolio | 1.7m $16.5m | Unchanged |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.03% of their portfolio | 1.5m $14.8m | Unchanged |
| Tekla Capital Management LLC 0.33% of their portfolio | 1.0m $10.2m | Unchanged |
| Nan Fung Group Holdings Ltd 1.87% of their portfolio | 613.2k $6.0m | First filing |
| Rock Springs Capital Management LP 0.11% of their portfolio | 568.3k $5.6m | Unchanged |
| PERCEPTIVE ADVISORS LLC 0.03% of their portfolio | 509.3k $5.0m | Added +254.7k |
| VANGUARD GROUP INC 0.00% of their portfolio | 481.5k $4.7m | Reduced -25.0k |
| Worth Venture Partners, LLC 1.72% of their portfolio | 469.2k $4.6m | Added +254.9k |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 275.9k $2.7m | Added +269.8k |
| FRAZIER MANAGEMENT LLC 0.22% of their portfolio | 241.0k $2.4m | Unchanged |
| Altium Capital Management LLC 0.50% of their portfolio | 219.9k $2.2m | New |
| JACOBS LEVY EQUITY MANAGEMENT, INC 0.01% of their portfolio | 195.2k $1.9m | Added +113.9k |
| BlackRock Inc. 0.00% of their portfolio | 185.1k $1.8m | Reduced -406.6k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 118.5k $1.2m | New |
| MARSHALL WACE, LLP 0.01% of their portfolio | 116.5k $1.1m | Added +62.4k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.02% of their portfolio | 110.0k $1.1m | Added +20.0k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 71.3k $700.0k | Reduced -45.0k |
| Taylor Wealth Management Partners 0.23% of their portfolio | 65.2k $641.0k | Added +210 |
| Ergoteles LLC 0.01% of their portfolio | 40.0k $393.0k | New |
| Tibra Equities Europe Ltd 0.11% of their portfolio | 36.9k $363.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 36.0k $353.0k | Added +12.3k |
| Raymond James Financial Services Advisors, Inc. 0.00% of their portfolio | 30.3k $297.0k | Added +1.0k |
| ExodusPoint Capital Management, LP 0.00% of their portfolio | 25.2k $248.0k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 25.1k $247.0k | Added +2.2k |
| HRT FINANCIAL LP 0.00% of their portfolio | 24.4k $239.0k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 24.2k $238.0k | Reduced -12.9k |
| Jump Financial, LLC 0.02% of their portfolio | 18.0k $177.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 16.0k $157.0k | Reduced -112.0k |
| NORTHERN TRUST CORP 0.00% of their portfolio | 14.8k $145.0k | Reduced -80.2k |
| HSBC HOLDINGS PLC 0.00% of their portfolio | 13.0k $130.0k | Added +8 |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 11.7k $115.0k | Reduced -1.1k |
| Trexquant Investment LP 0.01% of their portfolio | 11.2k $110.0k | New |
| US BANCORP \DE\ 0.00% of their portfolio | 10.6k $104.0k | New |
| TCI Wealth Advisors, Inc. 0.01% of their portfolio | 6.0k $59.0k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 5.9k $57.0k | Reduced -6.4k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 3.3k $32.0k | Reduced -13.8k |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 2.0k $20.0k | Added +1.5k |
| SIGNATUREFD, LLC 0.00% of their portfolio | 1.0k $10.0k | Unchanged |
| PANAGORA ASSET MANAGEMENT INC 0.00% of their portfolio | 566 $6.0k | Reduced -35.6k |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 284 $3.0k | Reduced -476 |
| UBS Group AG 0.00% of their portfolio | 284 $3.0k | Reduced -4.1k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 219 $2.0k | Reduced -1.7k |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 75 $1.0k | Reduced -2.1k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |